"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.

Bloomberg Businessweek Weekend: May 8th, 2026
38:41

Inside the AI Revival of the Infamous Three Mile Island Nuclear Plant
44:32

The Intersection of Human Psychology with AI
08:21